-
Mashup Score: 17The OncoAlert Newsletter - 2 month(s) ago
The Latest in Oncology delivered weekly to your inbox, a simple click and you are set to go!
Source: oncoalert.m-pages.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 5Overall Survival with Pembrolizumab in Early-Stage Triple-Negative Breast Cancer | NEJM - 2 month(s) ago
In patients with early-stage triple-negative breast cancer, the phase 3 KEYNOTE-522 trial showed significant improvements in pathological complete response and event-free survival with the addition…
Source: www.nejm.orgCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 5Overall Survival with Pembrolizumab in Early-Stage Triple-Negative Breast Cancer | NEJM - 2 month(s) ago
In patients with early-stage triple-negative breast cancer, the phase 3 KEYNOTE-522 trial showed significant improvements in pathological complete response and event-free survival with the addition…
Source: www.nejm.orgCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 5Overall Survival with Pembrolizumab in Early-Stage Triple-Negative Breast Cancer | NEJM - 2 month(s) ago
In patients with early-stage triple-negative breast cancer, the phase 3 KEYNOTE-522 trial showed significant improvements in pathological complete response and event-free survival with the addition…
Source: www.nejm.orgCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 17The OncoAlert Newsletter - 2 month(s) ago
The Latest in Oncology delivered weekly to your inbox, a simple click and you are set to go!
Source: oncoalert.m-pages.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 17The OncoAlert Newsletter - 2 month(s) ago
The Latest in Oncology delivered weekly to your inbox, a simple click and you are set to go!
Source: oncoalert.m-pages.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 17The OncoAlert Newsletter - 2 month(s) ago
The Latest in Oncology delivered weekly to your inbox, a simple click and you are set to go!
Source: oncoalert.m-pages.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 4Trastuzumab deruxtecan in HER2-positive advanced breast cancer with or without brain metastases: a phase 3b/4 trial - 2 month(s) ago
Nature Medicine – In the non-randomized phase 3b/4 DESTINY-Breast12 study, trastuzumab deruxtecan (T-DXd) treatment of patients with HER2+ advanced breast cancer and active or stable brain…
Source: www.nature.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 6Radiation Therapy for HPV-Positive Oropharyngeal Squamous Cell Carcinoma: An ASTRO Clinical Practice Guideline - PubMed - 2 month(s) ago
The role and practice of RT continues to evolve for HPV-associated OPSCC, and these guidelines inform best clinical practice based on the available evidence.
Source: pubmed.ncbi.nlm.nih.govCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 17The OncoAlert Newsletter - 2 month(s) ago
The Latest in Oncology delivered weekly to your inbox, a simple click and you are set to go!
Source: oncoalert.m-pages.comCategories: General Medicine News, Hem/OncsTweet
A warm welcome to join the @OncoAlert 🚨Newsletter The Latest in Oncology, weekly, simple and delivered straight to your inbox. As always, For Colleagues...By Colleagues!! https://t.co/DjFxZIg4PM